The global supply chain continues to face scrutiny, with port backups and product shortages grabbing headlines. However, as Chuck Forsaith, Vice President and Founder of HDA’s Pharmaceutical Cargo Security Coalition (PCSC), shared in a recent episode of the Pharmacy Crossroads podcast, there is another supply chain risk impacting trading partners throughout the healthcare distribution industry — which HDA’s PCSC has been diligently tracking and working to combat. Pharmacy Crossroads, hosted by pharmacy industry veteran Bruce Kneeland, provides an insider voice for the community pharmacy industry and is a member of the Pharmacy Podcast Network.
Texas-based Authentix, which provides authentication services to a range of sectors, launched in 2003 with a few dozen employees and a modest, but loyal customer base. These devoted customers, many of whom have worked with the company for nearly 20 years, are the foundation upon which this HDA-member service provider has grown into a global company with more than 400 staff and operations on five continents.
The World Health Organization has estimated that more than 13 million deaths around the globe are due to avoidable environmental causes stemming from climate change. Accordingly, this year’s World Health Day (April 7) theme is “Our Planet, Our Health,” which focuses on the political, social and commercial decisions that affect the environment as a factor in human health. The public and private sectors each can do their part on this front — and HDA believes that healthcare distributors have an important role to play in the health of the planet when it comes to delivering medications sustainably.
As March comes to a close, HDA is rounding out Women’s History Month celebrations by sharing perspectives from some of the incredible women making a difference within the distribution sector and the larger healthcare ecosystem. Interviews were conducted in conjunction with the recent Distribution Management Conference and other forums in support of HDA’s Faces of the Supply Chain video series, a new initiative of the Health Delivered campaign.
Healthcare distributors, as logistics experts of the supply chain, are constantly innovating to increase efficiencies, optimize operations and generate solutions for an ever-evolving ecosystem — while continuously ensuring the safe, efficient and reliable delivery of 10 million medicines and healthcare products every day.
Throughout the past year, HDA distributor members worked tirelessly to ensure the continued delivery of everyday, lifesaving medicines and support COVID-19 response efforts. Equipped with extensive logistics expertise, distributors used communication, collaboration and coordination with trading partners and at all levels of the government to aid and help protect the health of Americans across the country.
The health of the pharmaceutical supply chain depends on the expertise and ingenuity of the committed professionals working to help get lifesaving medicines and supplies to points of care as efficiently as possible.
With the deadline to implement the 2013 Drug Supply Chain Security Act (DSCSA) now less than two years away, HDA has released a new video that highlights the great progress that has been made by industry to implement DSCSA and some of the biggest challenges that still remain.
The coronavirus pandemic fostered and underscored the benefits of public-private partnerships as healthcare supply chain companies used their expertise and strengths to support the government’s response to an ongoing health crisis. The Milken Institute’s “2021 Partnering for Patients Forum” explored this topic during a panel discussion entitled, “Reimagining Public Health Partnerships: Lessons Learned from the Pandemic.”
Events spanning COVID-19 vaccine distribution to shipping containers held up at port have made the supply chain a “kitchen-table” issue during the past year. Many industries experienced notable disruptions in their delivery of goods and supplies; however, as noted by President and CEO Chip Davis, “[P]harmacies, health systems and physicians’ offices, more than 180,000 across the country, remain stocked with the lifesaving medications and vaccines patients need. That didn’t happen by accident.” Davis’ perspective was featured alongside healthcare supply chain association leaders as part of Chain Drug Review’s annual “Pharmacy Outlook” feature.
The two-year countdown to the Drug Supply Chain Security Act (DSCSA) deadline has begun. This final milestone, in combination with those already completed, will fundamentally change how product and data move together across the healthcare supply chain.
On October 7, HDA launched a three-part series to showcase how the distribution industry is helping create healthier communities through philanthropy, employee activism, partnerships with nonprofit organizations and more.
On October 7, we launched a three-part series to showcase how the distribution industry is making a difference in local communities across the country. In part one, we explored how HDA’s distributor members are leaving their imprint upon communities through corporate, foundation and employee support.
Long before the COVID-19 pandemic, HDA healthcare distributors recognized the vital role that philanthropy plays in building healthier communities — and the industry’s responsibility in leading these efforts.
Since the Drug Supply Chain Security Act (DSCSA) was enacted nearly 10 years ago, healthcare supply chain stakeholders have made steady progress in meeting regularly (through HDA and other settings) to discuss compliance strategies, establish recommended guidelines and build consensus on key milestones.
With the Delta variant surging across the United States, the fight against COVID-19 — and in turn, the most extensive vaccination campaign in our country’s history — is far from over. As the effects of the virus continue to reverberate, the Biden administration recently authorized booster shots, and the Food and Drug Administration granted full approval of the first COVID-19 vaccine in an effort to increase vaccination rates across the U.S.
Earlier this month, HDA published two new resources for supply chain stakeholders to ensure the proper handling of new products moving through the supply chain and removal of products that are recalled or need to be withdrawn.
HDA recently sponsored and participated in the Milken Institute’s 2021 Future of Health Summit. This year’s event, held on June 22–23, brought together industry experts, public health leaders and elected officials for insightful policy discussions on a variety of issues that are shaping healthcare in our country.
HDA President and CEO Chip Davis recently spoke at the 2021 BLC Online about the unique role of the healthcare distribution industry in combating COVID-19, how distributors continue to rise to its challenges and what is still needed to turn the corner on the pandemic, among other association priorities.
A new report estimates that the overall health costs of climate change already exceed $820 billion each year. The healthcare sector alone is responsible for nearly 5 percent of worldwide greenhouse gas emissions. According to a December 2020 Health Affairs study, “health damages stemming from U.S. [healthcare] pollution in 2013 [are] on the same order of magnitude as deaths from preventable medical errors.” Unfortunately, many of the most vulnerable communities are impacted by the harmful effects of climate change.
Discussions surrounding diversity, equity and inclusion (DE&I) are critically important to the healthcare distribution industry as this work ultimately strengthens the industry’s ability to deliver safe, affordable and efficient healthcare to patients across the nation. Earlier this month, HDA hosted a virtual discussion with four industry leaders who are fostering belonging within their organizations.
Protecting the steady supply of critical, lifesaving medicines to hospitals, pharmacies, providers and patients is a complex process in normal times. During COVID-19, patient demand for personal protective equipment (PPE) and other products has escalated significantly, adding new and unique challenges for HDA distributor members who are working around the clock to meet the daily healthcare needs of all Americans.
For the past year, I have watched the men and women of the healthcare distribution industry go above and beyond on a daily basis to make sure medicines, vaccines, PPE and other medical supplies reached patients and providers across the country. Their energy, determination and commitment have ensured a resilient supply chain during the most challenging days of the COVID-19 pandemic and a distribution network that has continued to deliver value each and every day.
On March 11, The 19th, an independent, nonprofit newsroom reporting on gender, politics and policy, hosted a virtual summit about healthcare equity in the context of the nation’s ongoing fight to defeat COVID-19. The event featured important and unique perspectives from the women directing the Biden-Harris administration’s pandemic response as well as other public health, health policy and healthcare industry leaders.
We have reached another pivotal moment in the fight against COVID-19: the Food and Drug Administration (FDA) has authorized Johnson & Johnson’s COVID-19 vaccine candidate for emergency use. With demand for vaccines currently outpacing supply, the addition of a third candidate is welcome news for Americans. Most importantly, a one-dose option that only requires refrigeration will provide greater flexibility in delivering vaccines to more individuals, including those in underserved and rural areas, with the ability to scale up production exponentially as we move into the spring and summer months.
On January 27, HDA joined other industry experts, public health leaders and elected officials for an insightful conversation about the manufacturing, distribution and administration of COVID-19 vaccines. Speakers and panelists from across the healthcare industry shared important perspectives with Steve Clemons, Editor-in-Chief of The Hill, on what can be done to support and strengthen the largest immunization campaign in our nation’s history. Below are a few takeaways from the discussion.
During one of the most ambitious immunization campaigns in our history, HDA President and CEO Chip Davis reinforced the distribution industry’s commitment to “answering the call” when assisting the federal, state and local governments as part of a nationwide vaccination push.
HDA will be carrying forward the early lessons learned from COVID-19 pandemic and supporting response efforts in 2021, writes President and CEO Chip Davis in the January 4 issue of Chain Drug Review — particularly as distributors play a role in the largest public vaccination effort in recent memory. Davis provided his perspective on the year ahead, along with other healthcare trade association leaders, as part of the publication’s 2021 “Pharmacy Outlook” feature.
Since the emergence of COVID-19, HDA distributor members have worked tirelessly to navigate the exceptional and unprecedented demands of this public health emergency. From managing unique inventory demands of the first hotspots, to ensuring access to emerging treatment options and testing, HDA members draw upon their extensive supply and distribution networks, logistics expertise and experience navigating public health emergencies. Moreover, distributors are committed to the public- and private-sector partnerships that are critical in combating COVID-19, fueling our recovery and improving pandemic resiliency for the future.
Since the enactment of the Drug Supply Chain Security Act in 2013, members of the pharmaceutical supply chain have undertaken efforts to meet each of the major milestones contained within the statute’s 10-year timeline to further secure the safety of the products being distributed. The industry’s progress to 2023 interoperability was top of mind as supply chain and other stakeholders came together at HDA’s recent Traceability Online Seminar.